Announced Wed, 17 Jun · 23:55 IST

HCG unit ethics committee suspended for 24 months by CDSCO

Regulatory & Legal View source PDF

HCG · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-3.1%1-day move
₹629.25
prior close
₹622.30
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.1+0.1-0.4-0.5-3.1-2.4-3.9-2.7-4.4-0.1+5.9+4.1
Up moveDown movePending
AI summary

CDSCO has suspended HCG's KR Unit Ethics Committee at Bangalore Institute of Oncology for 24 months, barring it from approving new clinical trials or BA/BE studies. Order received 16 June 2026. Alleged violations include delayed Serious Adverse Event reporting, missing conflict of interest disclosures, and missing meeting minutes. Impact is limited to this one committee; hospital operations, patient care, and other units are unaffected. Company sees no significant financial impact and is exploring legal remedies.

Likely market impact

Limited to one ethics committee; no major financial impact seen. Stock may face short-term pressure over regulatory risk.